{
    "title": "AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8580543/Drugmaker-AbbVie-profit-beats-Humira-helps-offset-COVID-19-hit.html",
    "date": "2020-07-31",
    "keywords": [
        "share",
        "botox",
        "company",
        "manojna",
        "maddipatla",
        "profit",
        "treatment",
        "demand",
        "covid19",
        "business",
        "unit",
        "recovery",
        "precovid",
        "end",
        "june",
        "inc",
        "friday",
        "blockbuster",
        "arthritis",
        "humira",
        "cushion",
        "allergan",
        "control",
        "wrinkle",
        "dependence",
        "patent",
        "expiry",
        "nonemergency",
        "shelterinplace",
        "spread",
        "coronavirus",
        "quarter",
        "basis",
        "mizuho",
        "analyst",
        "vamil",
        "divan",
        "brokerage",
        "abbvie",
        "majority",
        "officer",
        "richard",
        "gonzalez",
        "conference",
        "half",
        "year",
        "accretion",
        "deal",
        "forecast",
        "dec",
        "consensus",
        "estimate",
        "morning",
        "trading",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}